Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6021124 | Journal of Neuroimmunology | 2011 | 8 Pages |
Abstract
In myasthenia gravis (MG), the neuromuscular transmission is impaired mainly by auto-antibodies against the acetylcholine receptor (AChR) or MuSK. In about 5% of the MG patients, however, the auto-antigen is still unknown. We investigated whether these idiopathic MG patients (iMG) have auto-antibodies against ErbB proteins, which influence the AChR density at the NMJ. Our results show reduced mRNA expression levels of ErbB4 in thymus tissue of iMG patients compared to AChR-MG and non-MG patients, but we could not detect anti-ErbB antibodies in sera of iMG patients. Therefore, our results do not support a role for ErbB receptors as auto-antigens in iMG patients.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kathleen Vrolix, Erik H. Niks, Rozen Le Panse, Monique M. van Ostaijen-ten Dam, Anne-Hilde Muris, Cornelia M. Jol-van der Zijde, Maarten J.D. van Tol, Mario Losen, Peter C. Molenaar, Everardus J.J. van Zoelen, Sonia Berrih-Aknin, Marc H. De Baets,